Compugen Ltd. (CGEN) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Compugen Ltd.

Cue Biopharma, Inc.

Bionano Genomics, Inc.

Immunome, Inc.

CARA Therapeutics, Inc.

Carmell Corp.

NGM Biopharmaceuticals, Inc.

Kodiak Sciences, Inc.

Spruce Biosciences, Inc.

Anixa Biosciences, Inc.

IO Biotech, Inc.

Why is Compugen Ltd. ?

Positive results in Mar 26

NET SALES(HY) Higher at USD 69.51 MM
NET PROFIT(HY) Higher at USD 49.18 MM
ROCE(HY) Highest at 45.72%

With ROE of 34.40%, it has a very attractive valuation with a 1.88 Price to Book Value

Over the past year, while the stock has generated a return of 21.82%, its profits have risen by 348.4% ; the PEG ratio of the company is 0

Majority shareholders : Mutual Funds

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Compugen Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Compugen Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Compugen Ltd.

21.82%

-0.01

69.80%

S&P 500

25.41%

1.92

13.25%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

105.20%

EBIT Growth (5y)

24.53%

EBIT to Interest (avg)

-26.16

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.81

Sales to Capital Employed (avg)

0.52

Tax Ratio

47.42%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

16.38%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.88

EV to EBIT

1.52

EV to EBITDA

1.52

EV to Capital Employed

-1.13

EV to Sales

0.66

PEG Ratio

0.02

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

34.40%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company

NET SALES(HY)

Higher at USD 69.51 MM

NET PROFIT(HY)

Higher at USD 49.18 MM

ROCE(HY)

Highest at 45.72%

RAW MATERIAL COST(Y)

Fallen by -349.67% (YoY

CASH AND EQV(HY)

Highest at USD 280.59 MM

-14What is not working for the Company

NET SALES(Q)

At USD 2.18 MM has Fallen at -88.04%

DEBT-EQUITY RATIO (HY)

Highest at -138.45 %

OPERATING PROFIT(Q)

Lowest at USD -9.02 MM

PRE-TAX PROFIT(Q)

Lowest at USD -7.66 MM

NET PROFIT(Q)

Lowest at USD -7.67 MM

EPS(Q)

Lowest at USD -0.08

Here's what is working for Compugen Ltd.

Cash and Eqv

Highest at USD 280.59 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -349.67% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Compugen Ltd.

Net Sales

At USD 2.18 MM has Fallen at -88.04%

over average net sales of the previous four periods of USD 18.19 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit

At USD -7.66 MM has Fallen at -186.61%

over average net sales of the previous four periods of USD 8.85 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -7.67 MM has Fallen at -186.8%

over average net sales of the previous four periods of USD 8.84 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Profit

Lowest at USD -9.02 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -7.66 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -7.67 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

EPS

Lowest at USD -0.08

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debt-Equity Ratio

Highest at -138.45 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio